Back

Notification report


Full notification file


General information

Notification Number
B/ES/17/10

Member State to which the notification was sent
Spain

Date of acknowledgement from the Member State Competent Authority
22/03/2017

Title of the Project
Phase II extension study of CaspaCIDe T cells (BPX-501) from an HLA-partially matched family donor after negative selection of TCR αβ+T cells inn pediatric patients affected by hematological disorders

Proposed period of release:
01/07/2017 to 01/07/2019

Name of the Institute(s) or Company(ies)
Bellicum Pharmaceuticals, Inc., 2130 West Holcombe Blvd, Houston
Texas, 77030 USA;


3. Is the same GMO release planned elsewhere in the Community?
Yes:
United Kingdom; Italy;

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
Other: mammal

Identity of the GMO:
T cells obtained from haploidentical donor
- Genus: Homo
- Species: Homo Sapiens


Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HumanHomoSapiens---

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known